Marketwatch Cipla jumps 6% on completing Phase-3 clinical study of asthma drug Admin April 3, 2020 The generic would be used for treatment of asthma and chronic obstructive pulmonary disease. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
